Daiichi Sankyo (Germany)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
1.3K
Total Open
Publications
672
Total
Citations
35K
Open Access
Percentage
51%
Total
Publications
1.3K
Total Open
Publications
672
Total
Citations
35K
Breakdown
Publisher Open
32%
Both
16%
Other Platform Open
4%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
150
Hybrid 20%
127
No Guarantees 56%
348
Other Platform Open
Domain 77%
199
Institution 24%
63
Other Internet 14%
37
Preprint 5%
13
Public 1%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 201 |
DOI | Other Internet | 32 |
DANS - Data Archiving and Networked Services | Institution | 24 |
Research Square | Preprint | 12 |
Europe PMC | Domain | 9 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 7 |
King's College London - Research Portal | Institution | 7 |
universiteitleiden.nl OAI-PMH Repository | Institution | 6 |
University of Pisa - CINECA IRIS Institutial research information system | Institution | 5 |
UHasselt - Document Server@UHasselt | Institution | 4 |